Advertisement
OtherNeuropharmacology

Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed investigations with a Selective Allosteric mGluR1 Antagonist, FTIDC, (4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide)

Akio Satow, Shunsuke Maehara, Satoko Ise, Hirohiko Hikichi, Miyuki Fukushima, Gentaroh Suzuki, Toshifumi Kimura, Takeshi Tanaka, Satoru Ito, Hiroshi Kawamoto and Hisashi Ohta
Journal of Pharmacology and Experimental Therapeutics May 22, 2008, DOI: https://doi.org/10.1124/jpet.108.138107
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherNeuropharmacology

Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed investigations with a Selective Allosteric mGluR1 Antagonist, FTIDC, (4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide)

Akio Satow, Shunsuke Maehara, Satoko Ise, Hirohiko Hikichi, Miyuki Fukushima, Gentaroh Suzuki, Toshifumi Kimura, Takeshi Tanaka, Satoru Ito, Hiroshi Kawamoto and Hisashi Ohta
Journal of Pharmacology and Experimental Therapeutics May 22, 2008, DOI: https://doi.org/10.1124/jpet.108.138107
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement